Other OTC - Delayed Quote • USD
NanoSphere Health Sciences Inc. (NSHSF)
As of March 28 at 1:40 PM EDT. Market Open.
Key Executives
Amounts are as of December 31, 2022 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.
| Name | Title | Pay | Exercised | Year Born |
|---|---|---|---|---|
| Mr. Michael Alexander Iverson | Chairman of the Board & Interim CFO | 75k | -- | 1952 |
| Mr. Toby Lim | Corporate Secretary & Independent Director | -- | -- | -- |
| Dr. Richard Clark Kaufman B.S., M.S., Ph.D. | Co-Founder & Director | -- | -- | 1950 |
| Dr. Terry Grossman M.D. | Co-Founder & Chief Medical Director | -- | -- | -- |
| Ms. Kate Wells | Chief Marketing Officer of NanoSphere Health Sciences, LLC | -- | -- | -- |
NanoSphere Health Sciences Inc.
1090 West Georgia Street
Suite 488
Vancouver, BC V6E 3V7
Canada
- Sector:
- Healthcare
- Industry: Biotechnology
Description
NanoSphere Health Sciences Inc., a nano-biotechnology company, focuses on providing biologically active compounds in the United States and Canada. It offers NanoSphere Delivery System, a platform using nanotechnology in the bio delivery of supplements, nutraceuticals, and over-the-counter medications for the cannabis, pharmaceutical, and animal health industries. NanoSphere Health Sciences Inc. was incorporated in 2005 and is headquartered in Vancouver, Canada.
Corporate Governance
NanoSphere Health Sciences Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.
Recent Events
Recent Events Information Not Available
Upcoming Events
Upcoming Events Information Not Available